AC
RVPH

Armistice Capital’s REVIVA PHARMA HLDGS INC RVPH Stock Holding History

Armistice Capital’s Portfolio RVPH Stock Details RVPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-592,079
Closed -$432K – 408
2026
Q1 		$432K Buy
+592,079
New +$2.69M 0.01% 179
2025
Q3 		– Sell
-134,600
Closed -$1.03M – 381
2025
Q2 		$1.03M Buy
+134,600
New +$2.1M 0.02% 149
2025
Q1 		– Sell
-68,200
Closed -$2.47M – 275
2024
Q4 		$2.47M Sell
68,200
-91,100
-57% -$2.54M 0.03% 145
2024
Q3 		$4.59M Buy
+159,300
New +$3.54M 0.07% 129
2024
Q1 		– Sell
-88,200
Closed -$9.08M – 402
2023
Q4 		$9.08M Buy
88,200
+58,200
+194% +$5.22M 0.12% 96
2023
Q3 		$2.93M Sell
30,000
-11,200
-27% -$1.04M 0.04% 126
2023
Q2 		$4.83M Buy
+41,200
New +$5.22M 0.07% 119
2022
Q1 		– Sell
-35,379
Closed -$2.04M – 178
2021
Q4 		$2.04M Buy
35,379
+3,844
+12% +$274K 0.03% 122
2021
Q3 		$2.57M Sell
31,535
-4,200
-12% -$331K 0.04% 116
2021
Q2 		$3.47M Buy
+35,735
New +$3.6M 0.06% 99

Other funds holding RVPH

ECM
EMC Capital Management Houston, Texas $253M AUM
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
PUI
Purpose Unlimited Inc Toronto $2.62B AUM
MGI
Miller Global Investments Dallas, Texas $121M AUM
MWM
Mosley Wealth Management Anaheim, California $314M AUM

Armistice Capital's RVPH Position: Q2 2026 in Review

Armistice Capital sold out of REVIVA PHARMA HLDGS INC (RVPH) in Q2 2026, closing a stake of 592,079 shares — an estimated $432K sold.

Armistice Capital first reported a position in RVPH in Q2 2021 and held it in 10 quarters. The position peaked at $9.08M in Q4 2023. 5 funds tracked by Wall St. Rank hold RVPH as of Q2 2026.

  • Armistice Capital reported no remaining REVIVA PHARMA HLDGS INC position as of Q2 2026 after selling out during the quarter.
  • Armistice Capital sold 592,079 REVIVA PHARMA HLDGS INC shares in Q2 2026, an estimated $432K.
  • Armistice Capital first reported a position in REVIVA PHARMA HLDGS INC in Q2 2021 and held it in 10 quarters.
  • Armistice Capital's REVIVA PHARMA HLDGS INC position peaked at $9.08M in Q4 2023.
  • 5 funds tracked by Wall St. Rank held REVIVA PHARMA HLDGS INC as of Q2 2026.

Based on Armistice Capital's 13F filing for Q2 2026, filed 14 Aug 2026.